Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-27

Clinical Trial Update: Intracameral Antibiotic Safety Study [Phase 3]

View source ↗

Summary

Phase 3 intracameral antibiotic safety trial for cataract surgery is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin (moxifloxacin)
  • Vancomycin (vancomycin)

Snippet

Sponsor: Panhandle Eye Group, LLP | Conditions: Intracameral Antibiotics, Cataract Surgery | Phase 3 | Status: SUSPENDED